{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:47:36Z","timestamp":1788536856885,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Nature Fund Projects of Shanxi Science and Technology Department","award":["201901D111377"],"award-info":[{"award-number":["201901D111377"]}]},{"name":"The Scientific Research Project of Health commission of Shanxi Province","award":["2019044"],"award-info":[{"award-number":["2019044"]}]},{"name":"The Research Project Supported by Shanxi Scholarship Council of China","award":["2020-191"],"award-info":[{"award-number":["2020-191"]}]},{"name":"Science and Technology Innovation Project of Shanxi Province","award":["2020SYS08"],"award-info":[{"award-number":["2020SYS08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10067-022-06098-y","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T08:04:02Z","timestamp":1644998642000},"page":"1697-1708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Altered levels of circulating CD8+CXCR5+PD-1+T follicular cytotoxic cells in primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Xuwen","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangcong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-0286","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"6098_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sjogren\u2019s syndrome. Lancet 366:321\u2013331. https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","journal-title":"Lancet"},{"key":"6098_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/rheumatology\/ket401","volume":"53","author":"E Astorri","year":"2014","unstructured":"Astorri E, Scrivo R, Bombardieri M, Picarelli G, Pecorella I, Porzia A et al (2014) CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren\u2019s syndrome. Rheumatology (Oxford) 53:611\u2013620. https:\/\/doi.org\/10.1093\/rheumatology\/ket401","journal-title":"Rheumatology (Oxford)"},{"key":"6098_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40424","volume":"70","author":"VR Fonseca","year":"2018","unstructured":"Fonseca VR, Rom\u00e3o VC, Agua DA, Santos M, Presa DL, Ferreira AC et al (2018) The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sjogren\u2019s syndrome. Arthritis Rheumatol 70:774\u2013784. https:\/\/doi.org\/10.1002\/art.40424","journal-title":"Arthritis Rheumatol"},{"key":"6098_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coi.2016.08.003","volume":"43","author":"H Ueno","year":"2016","unstructured":"Ueno H (2016) T follicular helper cells in human autoimmunity. Curr Opin Immunol 43:24\u201331. https:\/\/doi.org\/10.1016\/j.coi.2016.08.003","journal-title":"Curr Opin Immunol"},{"key":"6098_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/QAI.0000000000001700","volume":"78","author":"PC Federico","year":"2018","unstructured":"Federico PC, Natalia AT, Maria TR (2018) Circulating CXCR5-expressing CD8+ T-cells are major producers of IL-21 and associate with limited HIV replication. J Acquir Immune Defic Syndr 78:473\u2013482. https:\/\/doi.org\/10.1097\/QAI.0000000000001700","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6098_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2017.09.039","volume":"361","author":"M Bai","year":"2017","unstructured":"Bai M, Zheng Y, Liu H, Su BW, Zhan Y, He H (2017) CXCR5+ CD8+ T cells potently infiltrate pancreatic tumors and present high functionality. Exp Cell Res 361:39\u201345. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.039","journal-title":"Exp Cell Res"},{"key":"6098_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Burger MC et al (2016) Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537:417\u2013421. https:\/\/doi.org\/10.1038\/nature19330","journal-title":"Nature"},{"key":"6098_CR8","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1084\/jem.20011565","volume":"195","author":"YM Kang","year":"2002","unstructured":"Kang YM, Zhang XY, Wagner UG, Yang HY, Beckenbaugh RD, Kurtin PJ et al (2002) CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 195:1325\u20131336. https:\/\/doi.org\/10.1084\/jem.20011565","journal-title":"J Exp Med"},{"key":"6098_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ni.3773","volume":"18","author":"Q Shan","year":"2017","unstructured":"Shan Q, Zeng ZH, Xing SJ, Li FY, Hartwig SM, Gullicksrud JA et al (2017) The transcription factor Runx3 guards cytotoxic CD8(+) effector T cells against deviation towards follicular helper T cell lineage. Nat Immunol 18:931\u2013939. https:\/\/doi.org\/10.1038\/ni.3773","journal-title":"Nat Immunol"},{"key":"6098_CR10","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/s41467-019-12446-5","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yu M, Zheng Y, Fu GP, Xin G, Zhu W et al (2019) CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance. Nat Commun 10:4415. https:\/\/doi.org\/10.1038\/s41467-019-12446-5","journal-title":"Nat Commun"},{"key":"6098_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1182\/bloodadvances","volume":"2","author":"KS Le","year":"2018","unstructured":"Le KS, Patricia AT, Tarte K, Rey FG, Granjeaud S, Orlanducci F et al (2018) CXCR5 and ICOS expression identifies a CD8 T-cell subset with T features in Hodgkin lymphomas. Blood Adv 2:1889\u20131900. https:\/\/doi.org\/10.1182\/bloodadvances","journal-title":"Blood Adv"},{"key":"6098_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"33","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 33:775\u2013787. https:\/\/doi.org\/10.1016\/j.cell.2008.05.009","journal-title":"Cell"},{"key":"6098_CR13","first-page":"11","volume":"2","author":"XL Tang","year":"2005","unstructured":"Tang XL, Smith TR, Kumar V (2005) Specific control of immunity by regulatory CD8 T cells. Cell Mol Immunol 2:11\u201319","journal-title":"Cell Mol Immunol"},{"key":"6098_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic selftolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141122","journal-title":"Annu Rev Immunol"},{"key":"6098_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.autrev.2010.03.006","volume":"9","author":"RK Dinesh","year":"2010","unstructured":"Dinesh RK, Skaggs BJ, La CA, Hahn BH, Singh RP (2010) CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev 9:560\u2013568. https:\/\/doi.org\/10.1016\/j.autrev.2010.03.006","journal-title":"Autoimmun Rev"},{"key":"6098_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12026-014-8529-9","volume":"59","author":"S Sinha","year":"2014","unstructured":"Sinha S, Itani FR, Karandikar NJ (2014) Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res 59:254\u2013265. https:\/\/doi.org\/10.1007\/s12026-014-8529-9","journal-title":"Immunol Res"},{"key":"6098_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0961203308089400","volume":"17","author":"A Tulunay","year":"2008","unstructured":"Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E (2008) CD8+CD28-, suppressive T cells in systemic lupus erythematosus. Lupus 17:630\u2013637. https:\/\/doi.org\/10.1177\/0961203308089400","journal-title":"Lupus"},{"key":"6098_CR18","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.4049\/jimmunol.174.9.5814","volume":"174","author":"J Brimnes","year":"2005","unstructured":"Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L (2005) Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 174:5814\u20135822. https:\/\/doi.org\/10.4049\/jimmunol.174.9.5814","journal-title":"J Immunol"},{"key":"6098_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.21944","volume":"67","author":"J Correale","year":"2010","unstructured":"Correale J, Villa A (2010) Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol 67:625\u2013638. https:\/\/doi.org\/10.1002\/ana.21944","journal-title":"Ann Neurol"},{"key":"6098_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature09370","volume":"467","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Verbinne B, Tang X, Lu L, Cantor H (2010) Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 467:328\u2013332. https:\/\/doi.org\/10.1038\/nature09370","journal-title":"Nature"},{"key":"6098_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) European Study Group on Classification Criteria for Sj\u00f6gren\u2019s Syndrome. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558. https:\/\/doi.org\/10.1136\/ard.61.6.554","journal-title":"Ann Rheum Dis"},{"key":"6098_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E et al (2010) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69:1103\u20131109. https:\/\/doi.org\/10.1136\/ard.2009.110619","journal-title":"Ann Rheum Dis"},{"key":"6098_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jcp.21.5.656","volume":"21","author":"DM Chisholm","year":"1968","unstructured":"Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sj\u00f6gren\u2019s disease. J Clin Pathol 21:656\u2013660. https:\/\/doi.org\/10.1136\/jcp.21.5.656","journal-title":"J Clin Pathol"},{"key":"6098_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/acr.22968","volume":"69","author":"SE Carsons","year":"2017","unstructured":"Carsons SE, Vivino FB, Parke A, Carteron N, Sankar V, Brasington R et al (2017) Treatment guidelines for rheumatologic manifestations of Sj\u00f6gren\u2019s Syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain. Arthritis Care Res (Hoboken) 69:517\u2013527. https:\/\/doi.org\/10.1002\/acr.22968","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6098_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB et al (2010) Lung involvement in patients with primary Sjogren\u2019s syndrome: what are the predictors? Rheumatol Int 30:1317\u20131324. https:\/\/doi.org\/10.1007\/s00296-009-1152-8","journal-title":"Rheumatol Int"},{"key":"6098_CR26","doi-asserted-by":"publisher","first-page":"6108342","DOI":"10.1155\/2020\/6108342","volume":"2020","author":"BC Li","year":"2020","unstructured":"Li BC, Guo QL, Wang YY, Su R, Gao C, Zhao JF et al (2020) Increased serum interleukin-2 levels are associated with abnormal peripheral blood natural killer cell levels in patients with active rheumatoid arthriti. Mediators Inflamm 2020:6108342. https:\/\/doi.org\/10.1155\/2020\/6108342","journal-title":"Mediators Inflamm"},{"key":"6098_CR27","first-page":"94","volume":"112","author":"CF Kampolis","year":"2018","unstructured":"Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM (2018) Prevalence and spectrum of symptomatic pulmonary involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 112:94\u2013101","journal-title":"Clin Exp Rheumatol"},{"key":"6098_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev 25:110\u2013123. https:\/\/doi.org\/10.1183\/16000617.0011-2016","journal-title":"Eur Respir Rev"},{"key":"6098_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.3543","volume":"17","author":"YA Leong","year":"2016","unstructured":"Leong YA, Chen YP, Ong HS, Wu D, Man K, Deleage C et al (2016) CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol 17:1187\u20131196. https:\/\/doi.org\/10.1038\/ni.3543","journal-title":"Nat Immunol"},{"key":"6098_CR30","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1172\/JCI96207","volume":"128","author":"S Ferrando-Martinez","year":"2018","unstructured":"Ferrando-Martinez S, Moysi E, Pegu A, Andrews S, Makamdop KN, Ambrozak D et al (2018) Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Inves 128:2089\u20132103. https:\/\/doi.org\/10.1172\/JCI96207","journal-title":"J Clin Inves"},{"key":"6098_CR31","doi-asserted-by":"publisher","first-page":"11234","DOI":"10.1074\/jbc.M111.324046","volume":"287","author":"RI Nurieva","year":"2012","unstructured":"Nurieva RI, Podd A, Chen YH, Alekseev AM, Yu M, Qi XP et al (2012) STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J Biol Chem 287:11234\u201311239. https:\/\/doi.org\/10.1074\/jbc.M111.324046","journal-title":"J Biol Chem"},{"key":"6098_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.intimp.2018.07.002","volume":"62","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Guo LQ, Sun HW, Xu JB, Ba T (2018) CXCR5+ CD8 T cells displayed higher activation potential despite high PD-1 expression, in tumor-involved lymph nodes from patients with thyroid cancer. Int Immunopharmacol 62:114\u2013119. https:\/\/doi.org\/10.1016\/j.intimp.2018.07.002","journal-title":"Int Immunopharmacol"},{"key":"6098_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","volume":"29","author":"A Vogelzang","year":"2008","unstructured":"Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C (2008) A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29:127\u2013137. https:\/\/doi.org\/10.1016\/j.immuni.2008.06.001","journal-title":"Immunity"},{"key":"6098_CR34","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1172\/JCI88625","volume":"126","author":"A Malik","year":"2016","unstructured":"Malik A, Sharma D, Zhu QF, Karki R, Guy CS, Vogel P et al (2016) IL-33 regulates the IgA-microbiota axis to restrain IL-1alpha-dependent colitis and tumorigenesis. J Clin Invest 126:4469\u20134481. https:\/\/doi.org\/10.1172\/JCI88625","journal-title":"J Clin Invest"},{"key":"6098_CR35","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1093\/rheumatology\/kez228","volume":"58","author":"J Lin","year":"2019","unstructured":"Lin J, Yu Y, Ma JL, Ren CY, Chen WQ (2019) PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus. Rheumatology (Oxford) 58:2188\u20132192. https:\/\/doi.org\/10.1093\/rheumatology\/kez228","journal-title":"Rheumatology (Oxford)"},{"key":"6098_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","volume":"6","author":"G Churlaud","year":"2015","unstructured":"Churlaud G, Pitoiset F, Jebbawi F, Lorenzon R, Bellier B, Rosenzwajg M et al (2015) Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy. Front Immunol 6:171. https:\/\/doi.org\/10.3389\/fimmu.2015.00171","journal-title":"Front Immunol"},{"key":"6098_CR37","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","volume":"77","author":"M Miao","year":"2018","unstructured":"Miao M, Hao ZY, Guo YY, Zhang XY, Zhang SX, Luo J et al (2018) Short-term and low-dose IL-2 therapy restores the Th17\/Treg balance in the peripheral blood of patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 77:1838\u20131840. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213036","journal-title":"Ann Rheum Dis"},{"key":"6098_CR38","first-page":"211","volume":"26","author":"M Eusebio","year":"2012","unstructured":"Eusebio M, Kraszula L, Kupczyk M, Kuna P, Pietruczuk M (2012) Low frequency of CD8+CD25+FOXP3(BRIGHT) T cells and FOXP3 mRNA expression in the peripheral blood of allergic asthma patients. J Biol Regul Homeost Agents 26:211\u2013220","journal-title":"J Biol Regul Homeost Agents"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06098-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T21:08:33Z","timestamp":1652994513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06098-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6098"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06098-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"12 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}